OTC Hangover Remedy Safety On Tap For FDA Advisory Committees
This article was originally published in The Pink Sheet
Executive Summary
CDER schedules an NDAC and DSRMAC joint meeting while also negotiating with industry stakeholders on a potential proposal for a user fee program to support FDA’s work on finalizing monographs or amending monographs with additional ingredients or indications.